Skip to main content
Premium Trial:

Request an Annual Quote

Shifting to Biomarkers, Proteome Systems Changes Name to Tyrian Diagnostics

NEW YORK (GenomeWeb News) – Proteome Systems’ shareholders have agreed to change the name of the company to Tyrian Diagnostics in order to reflect its shift toward a biomarker-based diagnostics business, the company said today.
Tyrian Diagnostics said the renaming completes the moves the company has been making to focus on biomarkers.
“The divestiture of the technology platform and an exit from the therapeutic business enabled the allocation of the appropriate resources to achieve corporate growth,” company CEO Jenny Harry said in a statement.
The Sydney, Australia-based company said in August it would shut down its drug development business and would close its office in Boston.
The company said at the time that it would retain the rights to a portfolio of assets covering compounds for dermatological and neurological indications, and that it would consider out-licensing opportunities.
The company’s ticker symbol on the Australian exchange will change from ASX-PXL to TDX on Nov. 19.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.